Alibaba Health Information Technology Limited (0241.HK)
HKD 3.45
(-0.29%)
HKD 3.45
(-0.29%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 27.02 Billion CNY | 0.98% |
| 2022 | 26.76 Billion CNY | 30.06% |
| 2021 | 20.57 Billion CNY | 32.6% |
| 2020 | 15.51 Billion CNY | 61.71% |
| 2019 | 9.59 Billion CNY | 88.32% |
| 2018 | 5.09 Billion CNY | 108.62% |
| 2017 | 2.44 Billion CNY | 414.15% |
| 2016 | 475.07 Million CNY | 739.43% |
| 2015 | 56.59 Million CNY | 90.27% |
| 2014 | 29.74 Million CNY | -38.24% |
| 2013 | 48.15 Million CNY | -87.73% |
| 2012 | 392.32 Million CNY | 0.26% |
| 2011 | 391.3 Million CNY | 24.63% |
| 2010 | 313.98 Million CNY | 24.02% |
| 2009 | 253.17 Million CNY | 4.54% |
| 2008 | 242.18 Million CNY | 15.17% |
| 2007 | 210.29 Million CNY | -25.62% |
| 2006 | 282.74 Million CNY | -32.21% |
| 2005 | 417.11 Million CNY | 57.81% |
| 2004 | 264.31 Million CNY | 51.8% |
| 2003 | 174.12 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 FY | 27.02 Billion CNY | 0.98% |
| 2023 Q4 | 14.07 Billion CNY | 0.0% |
| 2023 Q2 | 12.95 Billion CNY | 0.0% |
| 2022 Q4 | 15.26 Billion CNY | 0.0% |
| 2022 Q2 | 11.5 Billion CNY | 0.0% |
| 2022 FY | 26.76 Billion CNY | 30.06% |
| 2021 Q2 | 9.35 Billion CNY | 0.0% |
| 2021 FY | 20.57 Billion CNY | 32.6% |
| 2021 Q4 | 11.21 Billion CNY | 0.0% |
| 2020 Q4 | 8.35 Billion CNY | 0.0% |
| 2020 FY | 15.51 Billion CNY | 61.71% |
| 2020 Q2 | 7.16 Billion CNY | 0.0% |
| 2019 FY | 9.59 Billion CNY | 88.32% |
| 2019 Q2 | 4.11 Billion CNY | 0.0% |
| 2019 Q4 | 5.47 Billion CNY | 0.0% |
| 2018 Q2 | 1.87 Billion CNY | 0.0% |
| 2018 FY | 5.09 Billion CNY | 108.62% |
| 2018 Q4 | 3.21 Billion CNY | 0.0% |
| 2017 FY | 2.44 Billion CNY | 414.15% |
| 2017 Q2 | 889.73 Million CNY | 0.0% |
| 2017 Q4 | 1.55 Billion CNY | 0.0% |
| 2016 FY | 475.07 Million CNY | 739.43% |
| 2016 Q2 | 55.02 Million CNY | 0.0% |
| 2016 Q4 | 420.05 Million CNY | 0.0% |
| 2015 Q4 | 39.4 Million CNY | 0.0% |
| 2015 Q2 | 17.19 Million CNY | 0.0% |
| 2015 FY | 56.59 Million CNY | 90.27% |
| 2014 FY | 29.74 Million CNY | -38.24% |
| 2014 Q4 | 14.83 Million CNY | 0.0% |
| 2014 Q2 | 14.74 Million CNY | 0.0% |
| 2013 Q3 | 12.03 Million CNY | 142.53% |
| 2013 Q1 | 98.08 Million CNY | 1369.3% |
| 2013 FY | 48.15 Million CNY | -87.73% |
| 2013 Q4 | 16.98 Million CNY | 41.11% |
| 2013 Q2 | 4.96 Million CNY | -94.94% |
| 2012 Q2 | 97.82 Million CNY | 0.0% |
| 2012 FY | 392.32 Million CNY | 0.26% |
| 2012 Q4 | 6.67 Million CNY | -93.19% |
| 2012 Q3 | 98.08 Million CNY | 0.26% |
| 2012 Q1 | 97.82 Million CNY | 0.0% |
| 2011 Q2 | 78.49 Million CNY | 0.0% |
| 2011 Q3 | 97.82 Million CNY | 24.63% |
| 2011 Q4 | 97.82 Million CNY | 0.0% |
| 2011 FY | 391.3 Million CNY | 24.63% |
| 2011 Q1 | 78.49 Million CNY | 0.0% |
| 2010 Q2 | 63.29 Million CNY | 0.0% |
| 2010 FY | 313.98 Million CNY | 24.02% |
| 2010 Q4 | 78.49 Million CNY | 0.0% |
| 2010 Q1 | 63.29 Million CNY | 0.0% |
| 2010 Q3 | 78.49 Million CNY | 24.02% |
| 2009 Q2 | 60.54 Million CNY | 0.0% |
| 2009 FY | 253.17 Million CNY | 4.54% |
| 2009 Q1 | 60.54 Million CNY | 0.0% |
| 2009 Q3 | 63.29 Million CNY | 4.54% |
| 2009 Q4 | 63.29 Million CNY | 0.0% |
| 2008 Q4 | 60.54 Million CNY | 0.0% |
| 2008 Q2 | 52.57 Million CNY | 0.0% |
| 2008 Q1 | 52.57 Million CNY | 0.0% |
| 2008 FY | 242.18 Million CNY | 15.17% |
| 2008 Q3 | 60.54 Million CNY | 15.17% |
| 2007 Q1 | 70.68 Million CNY | 0.0% |
| 2007 Q3 | 52.57 Million CNY | -25.62% |
| 2007 Q4 | 52.57 Million CNY | 0.0% |
| 2007 Q2 | 70.68 Million CNY | 0.0% |
| 2007 FY | 210.29 Million CNY | -25.62% |
| 2006 Q2 | 104.27 Million CNY | 0.0% |
| 2006 Q3 | 70.68 Million CNY | -32.21% |
| 2006 Q4 | 70.68 Million CNY | 0.0% |
| 2006 FY | 282.74 Million CNY | -32.21% |
| 2006 Q1 | 104.27 Million CNY | 0.0% |
| 2005 Q2 | 66.07 Million CNY | 0.0% |
| 2005 FY | 417.11 Million CNY | 57.81% |
| 2005 Q4 | 104.27 Million CNY | 0.0% |
| 2005 Q1 | 66.07 Million CNY | 0.0% |
| 2005 Q3 | 104.27 Million CNY | 57.81% |
| 2004 Q1 | 43.53 Million CNY | 0.0% |
| 2004 Q3 | 66.07 Million CNY | 51.8% |
| 2004 FY | 264.31 Million CNY | 51.8% |
| 2004 Q2 | 43.53 Million CNY | 0.0% |
| 2004 Q4 | 66.07 Million CNY | 0.0% |
| 2003 Q3 | 43.53 Million CNY | 0.0% |
| 2003 FY | 174.12 Million CNY | 0.0% |
| 2003 Q4 | 43.53 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| China Healthwise Holdings Limited | 146.31 Million HKD | -18371.234% |
| Tycoon Group Holdings Limited | 1.19 Billion HKD | -2154.751% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 1.52 Billion HKD | -1672.297% |